Insider Trading July 2, 2026 04:09 PM

Castellum's COO Andrew Merriman Acquires Shares Under ESPP Discount

Executive purchase of 1,202 shares at $0.612 aligns with company's employee stock plan, as stock trades above 52-week lows despite year-to-date decline.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
CTM

Andrew Merriman, Chief Operating Officer of Castellum, Inc., executed a purchase of 1,202 shares of company common stock on July 1, 2026. The transaction, valued at $735, was facilitated through the Castellum, Inc. 2025 Employee Stock Purchase Plan. The acquisition price of $0.612 per share represented a 15% discount to the stock's closing price on the NYSE American LLC on June 30, 2026. Following this acquisition, Merriman's direct holdings in Castellum total 538,531 shares. The stock currently trades at $0.69, reflecting a 19% decline year-to-date, yet remains above its 52-week low of $0.48. Analyst assessments suggest the stock may be undervalued relative to its fair value, with expectations of profitability for the current year despite recent operational losses.

Castellum's COO Andrew Merriman Acquires Shares Under ESPP Discount
CTM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Castellum COO Andrew Merriman purchased 1,202 shares at $0.612 per share through the company's 2025 Employee Stock Purchase Plan, bringing his direct holdings to 538,531 shares.
  • Analysts project Castellum will achieve profitability this year despite recent losses, with the stock currently trading at $0.69, well above its 52-week low of $0.48 despite a 19% year-to-date decline.
  • Canterra Minerals Corporation released assay results from an eight-hole winter drill program at the Buchans Project in Newfoundland, totaling 2,386 meters across the Lundberg deposit, Two Level zone, and West Clementine target area.

Andrew Merriman, serving as the Chief Operating Officer for Castellum, Inc., completed a direct acquisition of company equity on July 1, 2026. The transaction involved the purchase of 1,202 shares of Castellum's common stock, resulting in a total capital outlay of $735. This executive buying activity was executed in strict adherence to the parameters established by the Castellum, Inc. 2025 Employee Stock Purchase Plan.

The specific execution price for these shares was recorded at $0.612 per share. This valuation mechanism reflects a calculated 15% discount applied to the closing price of Castellum's common stock on the NYSE American LLC on June 30, 2026. Market data indicates that the stock is currently trading at $0.69. This current valuation marks a significant contraction of 19% year-to-date. Despite this downward trajectory, the share price maintains a position well above its 52-week low of $0.48.

Post-transaction, Mr. Merriman's direct ownership stake in Castellum common stock stands at 538,531 shares. Independent analysis from InvestingPro indicates that the stock's current pricing may reflect undervaluation when measured against its Fair Value assessment. Furthermore, analyst projections anticipate that the company will achieve profitability during the current fiscal year, a notable shift given the company's recent history of operational losses.

In parallel corporate developments, Canterra Minerals Corporation has released assay results stemming from its winter drill program at the Buchans Project, located in Newfoundland. The drilling initiative encompassed eight distinct holes, yielding a total footage of 2,386 meters. This work was completed during February and March 2026.

The drilling operations specifically targeted the Lundberg deposit and the Two Level zone. Additionally, the program addressed geophysical anomalies identified within the West Clementine target area. These activities constitute a component of Canterra's broader exploration efforts within Newfoundland's Central Mining District. The company continues to assess the potential of these specific areas based on the recent analytical findings.

Investors are advised that these results may hold significance as they demonstrate Canterra's ongoing commitment to advancing its exploration projects. The assay data provides critical information that will directly inform future exploration strategies. Canterra's management team remains focused on leveraging these findings to guide subsequent operational steps in the region.

Risks

  • Castellum's stock has experienced a 19% decline year-to-date, indicating potential market volatility and investor skepticism despite projections of near-term profitability.
  • Canterra's exploration efforts in Newfoundland's Central Mining District face inherent geological and permitting risks, with future strategies dependent on the interpretation of recent assay data from the Lundberg deposit and West Clementine areas.

More from Insider Trading

Sionna Therapeutics Director Sells $5.27M in Stock Amid Mixed Analyst Outlook Jul 2, 2026 FDX Director Paul S. Walsh Executes $1.64 Million Share Sale Amid Strategic Corporate Shifts Jul 2, 2026 Hinge Health Chairman Gabriel Mecklenburg Executes $7.09 Million Stock Sale Under Pre-Arranged Plan Jul 2, 2026 Mid Penn Bancorp Director Albert Evans Executes $9,999 Share Purchase Near 52-Week High Jul 2, 2026 SentinelOne Chief Executive Executes $1.02 Million Stock Disposition Under Pre-Arranged Plan Jul 2, 2026